Bhubaneswar, May 29: The Odisha Government has placed the order for 2-deoxy-D-glucose (2DG), the oral antiviral drug for Covid-19 patients developed by Defence Research and Development Organisation (DRDO) in Collaboration with the Hyderabad-based Dr Reddy’s Pharma Laboratory (DRL), a senior official said on Saturday.
Speaking to media persons here, Additional Chief Secretary (Health) Pradipta Mohapatra said that the State Government has placed an order with Hyderabad-based DRL for purchasing 5000 sachets of 2DG drugs.
The anti-Covid drug, which was launched on May 17, has been priced at Rs 990 per sachet.
Sources said that clinical trial data show that the molecule helps in faster recovery of patients hospitalised with Covid-19, and reduces their dependence on supplemental oxygen.
The drug is available in powder form in a sachet, and can be taken orally after dissolving in water. It can reduce the hospital stay of Covid-19 patients, sources added.